YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Bharat Immuno
Bharat Immuno
BSE: 524663NSE: ISIN: INE994B01014

29th-Apr-2020 17:44Source: BSE

Bharat Immunologicals and Biologicals Corporation - Bharat Immunologicals & Biologicals Corporation Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd with respect to "interview of CEO of the Company on NDTV 24×7 news channel, wherein he had mentioned that the company is in process of developing/ testing the vaccine for COVID 19." Source: NDTV 24×7 dated April 28, 2020.

Bharat Immunologicals & Biologicals Corporation Ltd replied stating that "It is referred the email received from exchange and information is being provided that BIBCOL is not doing and research activity related to development of vaccine of Covid-19 and no official of BIBCOL has given any interview on NDTV or any other channel or media.

Hence information under Regulation 30 of SEBI LODR 2015 may please be treated as NIL."

More Announcements on:

1 2 3 4 5 Next >>